Manufacturing & Cell Line Development at Abzena
Published on September 4, 2017
Abzena has extensive experience in cGMP and non-GMP production for recombinant proteins, antibodies and conjugates products for preclinical and clinical materials. Abzena’s expertise in employing single-use technology allows for rapid turnaround times and cost effective solutions.
The post Manufacturing & Cell Line Development at Abzena appeared first on abzena.